Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Ozden Hatirnaz Ng"'
Autor:
Özden Hatırnaz Ng, Ahmet Emre Eşkazan
Publikováno v:
Translational Oncology, Vol 19, Iss , Pp 101394- (2022)
Externí odkaz:
https://doaj.org/article/1f528354e1434084a674eb15577ef571
Autor:
Bengisu Guner Yilmaz, Ozlem Akgun-Dogan, Ozkan Ozdemir, Bayram Yuksel, Ozden Hatirnaz Ng, Kaya Bilguvar, Beril Ay, Gulsah Sebnem Ozkose, Eylul Aydin, Ayca Yigit, Aybike Bulut, Fatma Nisa Esen, Serdar Beken, Selma Aktas, Atalay Demirel, Baran Cengiz Arcagok, Ebru Kazanci, İbrahim Bingol, Ozge Umur, Guntulu Sik, Ugur Isik, Melike Ersoy, Ayse Korkmaz, Agop Citak, Adil Mardinoglu, Ugur Ozbek, Yasemin Alanay
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
IntroductionRare and ultra-rare genetic conditions significantly contribute to infant morbidity and mortality, often presenting with atypical features and genetic heterogeneity that complicate management. Rapid genome sequencing (RGS) offers a timely
Externí odkaz:
https://doaj.org/article/09a390dd2ca34c80943a1799cdb86d67
Autor:
Nihat B. Agaoglu, Busra Unal, Connor P. Hayes, McKenzie Walker, Ozden Hatirnaz Ng, Levent Doganay, Nisan D. Can, Huma Q. Rana, Arezou A. Ghazani
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Objective Turkish genome is underrepresented in large genomic databases. This study aims to evaluate the effect of allele frequency in the Turkish population in determining the clinical utility of germline findings in breast cancer, includin
Externí odkaz:
https://doaj.org/article/0e8c822e43624d2f9734ff8febc97f18
Autor:
Gizem Önder, Ufuk Amanvermez, Cengiz Canpolat, Fatih Erbey, Davut Albayrak, Elif Ince, Gul Nihal Ozdemir, Yunus Murat Akcabelen, Nese Yarali, Namik Yasar Ozbek, Ikbal Okbozkaya, Turan Bayhan, Dilek Kacar, Omer Dogru, Koray Yalcin, Nihat Bugra Agaoglu, Ozkan Ozdemir, Ugur Ozbek, Ozden Hatirnaz Ng
Publikováno v:
HemaSphere, Vol 7, p e5926107 (2023)
Externí odkaz:
https://doaj.org/article/71c5b1baad7f4ff0a9fef7f453b46043
Autor:
Ozden Hatirnaz Ng, Ilayda Sahin, Yucel Erbilgin, Ozkan Ozdemir, Emrah Yucesan, Nazli Erturk, Merve Yemenici, Ozlem Akgun Dogan, Sibel Aylin Ugur Iseri, Ilhan Satman, Yasemin Alanay, Ugur Ozbek
Publikováno v:
Frontiers in Public Health, Vol 10 (2023)
Rare disease patients constitute a significant part of the healthcare system of all countries. However, the information on the experiences during disease processes and daily life of rare disease patients is still limited. So far, there is a small num
Externí odkaz:
https://doaj.org/article/04f3831b7dfa494d8f90a8d3bad42d91
Autor:
Raife Dilek Turan, Cihan Tastan, Derya Dilek Kancagi, Bulut Yurtsever, Gozde Sir Karakus, Samed Ozer, Selen Abanuz, Didem Cakirsoy, Gamze Tumentemur, Sevda Demir, Utku Seyis, Recai Kuzay, Muhammer Elek, Miyase Ezgi Kocaoglu, Gurcan Ertop, Serap Arbak, Merve Acikel Elmas, Cansu Hemsinlioglu, Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Cavit Kerem Kayhan, Fatma Tokat, Gurler Akpinar, Murat Kasap, Ayse Sesin Kocagoz, Ugur Ozbek, Dilek Telci, Fikrettin Sahin, Koray Yalcin, Siret Ratip, Umit Ince, Ercument Ovali
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract The SARS-CoV-2 virus caused the most severe pandemic around the world, and vaccine development for urgent use became a crucial issue. Inactivated virus formulated vaccines such as Hepatitis A and smallpox proved to be reliable approaches for
Externí odkaz:
https://doaj.org/article/0080510c27ab4fa68a13783ab005d11d
Autor:
Gozde Sir Karakus, Cihan Tastan, Derya Dilek Kancagi, Bulut Yurtsever, Gamze Tumentemur, Sevda Demir, Raife Dilek Turan, Selen Abanuz, Didem Cakirsoy, Utku Seyis, Samed Ozer, Omer Elibol, Muhammer Elek, Gurcan Ertop, Serap Arbak, Merve Acikel Elmas, Cansu Hemsinlioglu, Ayse Sesin Kocagoz, Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Ugur Ozbek, Dilek Telci, Fikrettin Sahin, Koray Yalcin, Siret Ratip, Ercument Ovali
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-19 (2021)
Abstract COVID-19 outbreak caused by SARS-CoV-2 created an unprecedented health crisis since there is no vaccine for this novel virus. Therefore, SARS-CoV-2 vaccines have become crucial for reducing morbidity and mortality. In this study, in vitro an
Externí odkaz:
https://doaj.org/article/46a25aaed32541e28966db05d0693f25
Autor:
Ozden Hatirnaz Ng, Sezer Akyoney, Ilayda Sahin, Huseyin Okan Soykam, Gunseli Bayram Akcapinar, Ozkan Ozdemir, Derya Dilek Kancagi, Gozde Sir Karakus, Bulut Yurtsever, Ayse Sesin Kocagoz, Ercument Ovali, Ugur Ozbek
Publikováno v:
PLoS ONE, Vol 16, Iss 12 (2021)
The Coronavirus Disease 2019 (COVID-19) was declared a pandemic in March 2020 by the World Health Organization (WHO). As of May 25th, 2021 there were 2.059.941 SARS-COV2 genome sequences that have been submitted to the GISAID database, with numerous
Externí odkaz:
https://doaj.org/article/c47e117f5de54f84a0a4c49333b66e09
Autor:
Tugce Sudutan, Yucel Erbilgin, Ozden Hatirnaz Ng, Serap Karaman, Zeynep Karakas, Fulya Kucukcankurt, Tiraje Celkan, Cetin Timur, Gul Nihal Ozdemir, Sadan Hacısalihoglu, Sema Aylan Gelen, Müge Sayitoğlu
Publikováno v:
Leukemia & Lymphoma. 63:2931-2939
B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is a heterogeneous malignancy and consists of several genetic abnormalities. Some of these abnormalities are used in clinics for risk calculation and treatment decisions. Patients with ZNF384 re
Autor:
Sinem Firtina, Yucel Erbilgin, Ozden Hatirnaz Ng, Serap Karaman, Zeynep Karakas, Tulin Tiraje Celkan, Sema Aylan Gelen, Yildiz Yildirmak, Ugur Ozbek, Muge Sayitoglu
The tumor suppressor protein 53 (TP53) gene is one of the most studied genes in cancer. Although TP53 variants are rare events in acute leukemia, recent observations showed that relapse samples might harbor TP53 variants. Here, we aimed to determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7e388715082e53d1526f628721698a